UMIN ID: UMIN000002175
Registered date:10/07/2009
Comparison of the clinical responses by the dosage of once or triple a week of MTX in patients with rheumatoid Arthritis
Basic Information
Recruitment status | Complete: follow-up continuing |
---|---|
Health condition(s) or Problem(s) studied | Rheumatoid Arthritis |
Date of first enrollment | 2009/06/01 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | MTX, once a week MTX, triple a week |
Outcome(s)
Primary Outcome | DAS28(CRP) |
---|---|
Secondary Outcome | EULAR Criteria Patient's Judgement |
Key inclusion & exclusion criteria
Age minimum | 16years-old |
---|---|
Age maximum | 80years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Disqualified in patients with rheumatoid arthritis who judged by a doctor |
Related Information
Primary Sponsor | POEM study group |
---|---|
Secondary Sponsor | None |
Source(s) of Monetary Support | None,None |
Secondary ID(s) |
Contact
public contact | |
Name | Motoriro Oribe |
Address | 1-8-15, Higasioomichi, Oita-city, Oita, Japan Japan |
Telephone | 097-513-7123 |
oribe-riuma@iris.ocn.ne.jp | |
Affiliation | Oribe Rheumatism Clinic Rheumatology |
scientific contact | |
Name | Motoriro Oribe |
Address | 1-8-15, Higasioomichi, Oita-city, Oita, Japan Japan |
Telephone | 097-513-7123 |
Affiliation | Oribe Rheumatism Clinic Rheumatology |